Koniku Overview
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
- Investors
-
36
Koniku General Information
Description
Developer of an organic neurocomputation platform designed to interface with the real world through real biological neurons. The company's platform is focused on two related technologies, odor positioning and the odor surveillance system that replicates sensitivity and specificity levels only seen in biological systems, delivering organ-on-chip and brain-on-chip preclinical testing services, enabling developers to build devices to map all volatile organic compounds that touch human life.
Contact Information
Website
www.koniku.comCorporate Office
- 740 Heinz Avenue
- Berkeley, CA 94710
- United States
Corporate Office
- 740 Heinz Avenue
- Berkeley, CA 94710
- United States
Koniku Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Later Stage VC | 01-Nov-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 31-Dec-2021 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 14-May-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 10-Apr-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 02-Aug-2016 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 01-Feb-2016 | $100K | $100K | Completed | Product Development | |
| 1. Grant | 22-Apr-2015 | $10K | Completed | Startup |
Koniku Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A9 | ||||||||
| Series A8 | ||||||||
| Series A6 | ||||||||
| Series A5 | ||||||||
| Series A4 | ||||||||
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A7 | 810,000 | $0.000010 | $2.26 | $2.26 | 1x | $2.26 | 2.95% | |
| Series A1 | 3,561,050 | $0.000010 | $0.49 | $0.49 | 1x | $0.49 | 12.96% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Koniku Comparisons
Industry
Financing
Details
Koniku Competitors (5)
One of Koniku’s 5 competitors is Aromyx, a Formerly VC-backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aromyx | Formerly VC-backed | Mountain View, CA | ||||
| Aryballe | Venture Capital-Backed | Grenoble, France | ||||
| Owlstone Medical | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Ping An Good Doctor/Unisound JV | Corporate Backed or Acquired | Shanghai, China | ||||
| Teladoc Health | Formerly VC-backed | New York, NY |
Koniku Patents
Koniku Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240027345-A1 | Detection of volatile organic compounds in air | Inactive | 25-Jul-2022 | ||
| WO-2024026229-A1 | Detection of volatile organic compounds in air | Inactive | 25-Jul-2022 | ||
| WO-2022250988-A1 | System and methods for detection of compounds and metabolites | Inactive | 24-May-2021 | ||
| WO-2022241295-A2 | Engineered cells for expressing olfactory receptors and methods for their use | Inactive | 14-May-2021 | ||
| WO-2022241295-A3 | Engineered cells for expressing olfactory receptors and methods for their use | Inactive | 14-May-2021 | G01N33/0057 |
Koniku Signals
Koniku Investors (36)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Half Court Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Andon Okapi | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Koniku FAQs
-
Where is Koniku headquartered?
Koniku is headquartered in Berkeley, CA.
-
What is the size of Koniku?
Koniku has 12 total employees.
-
What industry is Koniku in?
Koniku’s primary industry is Biotechnology.
-
Is Koniku a private or public company?
Koniku is a Private company.
-
What is Koniku’s current revenue?
The current revenue for Koniku is .
-
How much funding has Koniku raised over time?
Koniku has raised $46.5M.
-
Who are Koniku’s investors?
Half Court Ventures, , Andon Okapi, , and are 5 of 36 investors who have invested in Koniku.
-
Who are Koniku’s competitors?
Aromyx, Aryballe, Owlstone Medical, Ping An Good Doctor/Unisound JV, and Teladoc Health are competitors of Koniku.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process